One Stop Systems (OSS) Q2 2026 Earnings Call Transcript

One Stop Systems (OSS) reported Q2 revenue of $9.3M (+62.3% YoY) alongside record bookings of $15.1M (YTD $30M) and a 1.7 book-to-bill ratio, indicating accelerating demand for ruggedized edge compute. Full-year 2026 revenue guidance was raised to +25% to +30% from +20% to +25%, with gross margin guidance reiterated at ~40% (Q2 gross margin 39.1% vs 41.3% YoY due to a higher mix of early-stage, lower-margin customer-funded development). Despite a $6.25M one-time legal settlement that drove a GAAP net loss of $7.3M ($0.29/share), non-GAAP net loss was only $0.2M and adjusted EBITDA loss improved to $0.3M, while cash stood at $31.4M with no debt.

Analysis

OSS is moving from “project vendor” to “program supplier,” and that matters more than the headline revenue beat. The key mechanism is conversion: once a rugged compute platform gets designed into a vehicle, ship, or medical/industrial system, switching costs rise and follow-on orders become less cyclical. That makes the real comp not other microcaps, but defense electronics names like MRCY/CW/BHE-style platforms and even larger edge-infrastructure beneficiaries such as NVDA at the component layer; OSS is trying to capture the integration premium at the edge.

The near-term risk is that the market may over-interpret bookings as earnings power. A growing share of revenue is still early-stage engineering and low-rate production, which supports top-line visibility but suppresses margin until scale arrives; that argues for a 1-3 quarter lag between order wins and meaningful operating leverage. The inventory build is prudent if lead times stay tight, but it also raises the penalty if a government award slips or commercial conversions slow—working capital can turn from de-risking tool to cash drag quickly.

Contrarian view: consensus will likely focus on record bookings and miss how dependent the thesis is on a handful of long-cycle defense procurement paths. If Army/shipboard evaluations slip into FY27 or a continuing resolution delays funding, the stock can de-rate despite good call commentary. The real falsifier is not one soft quarter of revenue; it is a book-to-bill falling back toward 1.0, gross margin failing to migrate above the high-30s as programs mature, or cash burn re-accelerating enough to make the shelf renewal more than routine flexibility.

Key Decisions for Investors

• Long OSS into any post-earnings pullback below the first-day VWAP; treat it as a 6-12 month conversion story, not a one-quarter trade. Target upside comes from bookings translating into production revenue and margin expansion toward the mid-40s.
• Pair trade: long OSS / short MRCY for 1-3 months. OSS has more operating torque from new program wins and a cleaner balance sheet, while MRCY is more exposed to slower defense procurement conversion.
• If you want convexity, buy OSS call spreads 3-6 months out rather than outright calls; the stock should rerate on follow-on order announcements, but volatility is high and liquidity is limited.
• Set a risk alert if book-to-bill drops below 1.2 or gross margin prints under 37% for a second consecutive quarter; that would signal the current growth mix is not converting into scalable economics.
• Watch for a better entry after any shelf-registration noise or if the market overreacts to the legal settlement; those are likely to be technical pressures rather than fundamental deterioration.